skip to main content
cardiology & thrombosisscoring tool

Padua VTE Prediction Score

iatroX editorial team · Updated · Record checked · editorial policy

The Padua Prediction Score stratifies acutely ill medical inpatients by VTE risk to guide thromboprophylaxis decisions. A score ≥4 identifies high-risk patients who should receive pharmacologic prophylaxis.

inputs

evidence

derivation

Derived by Barbar et al. (J Thromb Haemost 2010) from a prospective cohort of 1,180 medical inpatients at Padua University Hospital.

validation

In the derivation cohort, VTE occurred in 11% of high-risk (≥4) vs 0.3% of low-risk (<4) patients. Validated in subsequent cohorts. The score has been endorsed by multiple VTE prevention guidelines.

guideline endorsements

ACCP/CHEST 2012 Antithrombotic Guidelines: recommend Padua for medical inpatient VTE risk assessment. NICE NG89 (VTE in over 16s): similar risk assessment principles. ASH 2019 VTE prevention guidelines reference Padua.

references
  1. Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450-2457.PMID: 20738765
  2. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e195S-e226S.PMID: 22315261
  3. NICE Guideline NG89. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. 2018 (updated 2019).link ↗